News (Media Awareness Project) - US CA: PUB LTE: Reviving Lotronex, Banning Marijuana |
Title: | US CA: PUB LTE: Reviving Lotronex, Banning Marijuana |
Published On: | 2001-06-03 |
Source: | Los Angeles Times (CA) |
Fetched On: | 2008-01-25 17:53:37 |
REVIVING LOTRONEX, BANNING MARIJUANA
Re "FDA Moving to Revive Deadly Drug," May 30: Hold the phone. We have the
Food and Drug Administration reconsidering the withdrawal of Lotronex
despite new evidence of life-threatening complications, while the Supreme
Court has made medical marijuana (which, to my knowledge, is not
life-threatening) prohibited.
What could possibly explain this? I suppose a little case of ischemic
colitis just doesn't compare with the horrific threat that the smoking of
marijuana will lead to harder drugs. As if those suffering with cancer and
AIDS could be any less concerned with this.
If GlaxoSmithKline were allowed to grow marijuana in its labs, it would be
offered in every conceivable packaging, with full FDA approval and with the
government standing first in line collecting taxes. That isn't smoke in the
air I smell, it's money, and it's outrageous.
Bruce Phillips
Los Angeles
Re "FDA Moving to Revive Deadly Drug," May 30: Hold the phone. We have the
Food and Drug Administration reconsidering the withdrawal of Lotronex
despite new evidence of life-threatening complications, while the Supreme
Court has made medical marijuana (which, to my knowledge, is not
life-threatening) prohibited.
What could possibly explain this? I suppose a little case of ischemic
colitis just doesn't compare with the horrific threat that the smoking of
marijuana will lead to harder drugs. As if those suffering with cancer and
AIDS could be any less concerned with this.
If GlaxoSmithKline were allowed to grow marijuana in its labs, it would be
offered in every conceivable packaging, with full FDA approval and with the
government standing first in line collecting taxes. That isn't smoke in the
air I smell, it's money, and it's outrageous.
Bruce Phillips
Los Angeles
Member Comments |
No member comments available...